Skip to main content
Premium Trial:

Request an Annual Quote

Celmatix Forms Therapeutics Discovery Division

NEW YORK (GenomeWeb) — Celmatix said today that it has launched a new therapeutics division focused on women's health indications with high unmet need including reproductive disorders and menopause.

Called Celmatix Biosciences, the new division will use Celmatix's Reproductive Atlas program — which is combining biological annotations from peer-reviewed literature with genomic data associated with lifestyle, diet, environment, and reproductive outcomes — to power its drug-discovery activities.

Celmatix Biosciences' most advanced program is in premature ovarian failure and currently in the lead optimization and selection stage, Celmatix said. The unit is also conducting target discovery research in endometriosis, polycystic ovary syndrome, and — with undisclosed funding from the Bill & Melinda Gates Foundation — female contraception.

The launch of Celmatix Biosciences comes about one year after New York City-based Celmatix kicked off expansion efforts following the receipt of $4.5 million in funding from the New York City Regional Economic Development Council and New York State Department of Health approval for its Fertilome multi-gene panel test for reproductive health conditions.

The Scan

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.

Algorithm Teases Out Genetic Ancestry in Individuals at Biobank Scale

Researchers develop an algorithm known as Rye to tease apart ancestry fractions in admixed individuals at a biobank-scale, applying it to 488,221 UK Biobank participants in Nucleic Acids Research.

Multi-Ancestry Analysis Highlights Comparable Common Variants at Complex Trait-Linked Loci

Researchers in Nature Genetics examine common variants implicated in more than three dozen conditions, estimating genetic effect similarities across ancestry tracts in admixed individuals.

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.